Scientific Sessions 2025  /  Genetic Insights and Precision Approaches in Congenital Heart Disease: Early Risk Prediction and Therapeutic Strategies  /  Are personalized therapies to treat (or prevent) congenital heart disease on the horizon?
Logo

American Heart Association

  38
  0

Final ID:

Are personalized therapies to treat (or prevent) congenital heart disease on the horizon?

  • Gelb, Bruce  ( ICAHN SCHOOL MEDICINE , New York , New York , United States )
  • Oh, Hidemasa  ( Okayama University Hospital , Okayama , Japan )
  • Wu, Sean  ( STANFORD UNIVERSITY , Stanford , California , United States )
  • Ranade, Sanjeev  ( Sanford Burnham Prebys Institute , La Jolla , California , United States )
  • Pu, William  ( Boston Children s Hospital , Boston , Massachusetts , United States )
    • Author Disclosures:
    Bruce Gelb: DO have relevant financial relationships ; Consultant:BioMarin:Active (exists now) ; Royalties/Patent Beneficiary:Correlegan:Active (exists now) ; Royalties/Patent Beneficiary:Prevention Genetics:Active (exists now) ; Royalties/Patent Beneficiary:LabCorp:Active (exists now) ; Royalties/Patent Beneficiary:GeneDx:Active (exists now) ; Consultant:Think Bioscience:Active (exists now) | Hidemasa Oh: No Answer | Sean Wu: DO NOT have relevant financial relationships | Sanjeev Ranade: DO NOT have relevant financial relationships | William Pu: DO have relevant financial relationships ; Research Funding (PI or named investigator):Sarepta:Past (completed) ; Consultant:SOLID:Active (exists now) ; Other (please indicate in the box next to the company name):Ionis -- in kind support (oligos):Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Genetic Insights and Precision Approaches in Congenital Heart Disease: Early Risk Prediction and Therapeutic Strategies

Sunday, 11/09/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
The heritable basis of congential heart disease - is it genetic?

Chatfield Kathryn, Xiao Feng, Gelb Bruce

When is genetic testing indicated in congenital heart disease, and what should be ordered?

Weaver Kathryn, Roberts Amy, Smith Catherine

More abstracts from these authors:
Functional siRNA Screen Reveals Core Regulators of Hypoplastic Left Heart Syndrome Cardiomyocyte Defects

Cimarosti Bastien, Marchant James, Colas Alexandre, Ranade Sanjeev

Transcriptional Enhancer Regulation of Heart Development and Disease

Pu William

You have to be authorized to contact abstract author. Please, Login
Not Available